AH Lisanti Capital Growth »

Lenz Therapeutics shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 88k 46.58
2025-06-30 $1.1M 36k 29.31
2025-03-31 $660k 26k 25.71

More positions owned by AH Lisanti Capital Growth

Kratos Defense & Sec Solutio Com New (KTOS)
Sterling Construction Company (STRL)
Bwx Technologies (BWXT)
Modine Manufacturing (MOD)
Biosante Pharmaceuticals (ANIP)
Mercury Computer Systems (MRCY)
Construction Partners Com Cl A (ROAD)
Zeta Global Holdings Corp Cl A (ZETA)
Ban (TBBK)
American Superconductor Corp Shs New (AMSC)
John Bean Technologies Corporation (JBTM)
Boot Barn Hldgs (BOOT)
Impinj (PI)
Mp Materials Corp Com Cl A (MP)
Transmedics Group (TMDX)

View all positions for AH Lisanti Capital Growth

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
BlackRock
Vanguard Group
UBS Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Morgan Stanley
Geode Capital Management

View all funds holding Lenz Therapeutics